RxDoctor Payments Data

Sean McIntosh

Family Medicine · O Fallon, MONPI 1700997731

Payments from drug & device makers

$545in general payments, 2019–2025

Across 31 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$255
  • GSK$125
  • Abbott$46
  • Novo Nordisk$45
  • Almatica Pharma LLC$16
  • Amgen$16
  • plus $42 from 3 others

What the payments were for

  • Food & beverage$545100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie11$255
GSK8$125
Abbott4$46
Novo Nordisk3$45
Almatica Pharma LLC1$16
Amgen1$16
Pfizer1$14
Modernatx, Inc.1$14
AstraZeneca1$14

How this compares

$545 in reported general payments places this provider in the 55th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$94,629
Medicare patients
269
Services billed
1,226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban124$138,165
OzempicSemaglutide45$58,688
JanuviaSitagliptin Phosphate27$38,933
MounjaroTirzepatide28$33,010
ArexvyRsvpref3 Antigen/As01e/Pf118$29,165
TradjentaLinagliptin20$25,430
JardianceEmpagliflozin30$23,804
EntrestoSacubitril/Valsartan11$17,153
Levothyroxine Sodium522$5,432
Atorvastatin Calcium471$4,667
SynthroidLevothyroxine Sodium50$3,978
Colesevelam Hcl31$3,285
Metoprolol Succinate210$3,247
Amlodipine Besylate485$3,014
Rosuvastatin Calcium232$2,991

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$14$139,594136 claims
Novo NordiskOzempic$45$58,68845 claims
GSKArexvy$125$29,165118 claims
AbbVieSynthroid$255$3,97850 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in O Fallon

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →